274 related articles for article (PubMed ID: 7419650)
1. Simultaneous determination of phenylbutazone and its metabolites in plasma and urine by high-performance liquid chromatography.
Marunaka T; Shibata T; Minami Y; Umeno Y
J Chromatogr; 1980 Sep; 183(3):331-8. PubMed ID: 7419650
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous high-performance liquid chromatographic determination of suxibuzone and its metabolites in plasma and urine.
Marunaka T; Shibata T; Minami Y; Umeno Y; Shindo T
J Pharm Sci; 1980 Nov; 69(11):1258-61. PubMed ID: 7452452
[TBL] [Abstract][Full Text] [Related]
3. Determination of phenylbutazone and oxyphenbutazone in plasma and urine samples of horses by high-performance liquid chromatography and gas chromatography-mass spectrometry.
Neto LM; Andraus MH; Salvadori MC
J Chromatogr B Biomed Appl; 1996 Apr; 678(2):211-8. PubMed ID: 8738024
[TBL] [Abstract][Full Text] [Related]
4. Solid-phase extraction for the high-performance liquid chromatographic determination of indomethacin, suxibuzone, phenylbutazone and oxyphenbutazone in plasma, avoiding degradation of compounds.
Caturla MC; Cusido E
J Chromatogr; 1992 Oct; 581(1):101-7. PubMed ID: 1429991
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of phenylbutazone and oxyphenbutazone in plasma by high-speed liquid chromatography.
Pound NJ; Sears RW
J Pharm Sci; 1975 Feb; 64(2):284-7. PubMed ID: 1127584
[TBL] [Abstract][Full Text] [Related]
6. Oxyphenbutazone and phenylbutazone determination in plasma and urine by GLC.
Bruce RB; Maynard WR; Dunning LK
J Pharm Sci; 1974 Mar; 63(3):446-8. PubMed ID: 4820382
[No Abstract] [Full Text] [Related]
7. [Determination of bumadizone, phenylbutazone and oxyphenbutazone in human plasma by high-performance liquid chromatography (author's transl)].
Spahn H; Mutschler E
Arzneimittelforschung; 1981; 31(3):495-9. PubMed ID: 6894379
[TBL] [Abstract][Full Text] [Related]
8. Direct injection HPLC method for the determination of phenylbutazone and oxyphenylbutazone in serum using a semipermeable surface column.
Haque A; Stewart JT
J Pharm Biomed Anal; 1997 Oct; 16(2):287-93. PubMed ID: 9408846
[TBL] [Abstract][Full Text] [Related]
9. Determination by high-performance liquid chromatography of phenylbutazone in samples of plasma from fighting bulls.
Marti MI; Sánchez GC; Jiménez H; Cachán G; Castro de CM; Cuadrado AL
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Mar; 769(1):119-26. PubMed ID: 11936684
[TBL] [Abstract][Full Text] [Related]
10. A supercritical fluid chromatographic method using packed columns for phenylbutazone and oxyphenbutazone in serum, and for phenylbutazone in a dosage form.
Simmons BR; Jagota NK; Stewart JT
J Pharm Biomed Anal; 1995 Jan; 13(1):59-64. PubMed ID: 7718635
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of hydrocortisone, dexamethasone, indomethacin, phenylbutazone and oxyphenbutazone in equine serum by high-performance liquid chromatography.
Grippa E; Santini L; Castellano G; Gatto MT; Leone MG; Saso L
J Chromatogr B Biomed Sci Appl; 2000 Jan; 738(1):17-25. PubMed ID: 10778922
[TBL] [Abstract][Full Text] [Related]
12. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse.
Lees P; Taylor JB; Maitho TE; Millar JD; Higgins AJ
Cornell Vet; 1987 Apr; 77(2):192-211. PubMed ID: 3568689
[TBL] [Abstract][Full Text] [Related]
13. High-performance of liquid chromatographic determination of [3,4-di-(4-methoxyphenyl)-5-isoxazolyl]acetic acid and its metabolites in human plasma and urine.
Marunaka T; Maniwa M
J Chromatogr; 1987 Nov; 422():227-33. PubMed ID: 3501788
[TBL] [Abstract][Full Text] [Related]
14. Screening, quantification, and confirmation of phenylbutazone and oxyphenbutazone in equine plasma by liquid chromatography-tandem mass spectrometry.
You Y; Uboh CE; Soma LR; Guan F; Li X; Rudy JA; Chen J
J Anal Toxicol; 2009; 33(1):41-50. PubMed ID: 19161668
[TBL] [Abstract][Full Text] [Related]
15. Phenylbutazone and its metabolites in plasma and urine of thoroughbred horses: population distributions and effects of urinary pH.
Houston T; Chay S; Woods WE; Combs G; Kamerling S; Blake JW; Edmundson AG; Vessiney R; Tobin T
J Vet Pharmacol Ther; 1985 Jun; 8(2):136-49. PubMed ID: 4020945
[TBL] [Abstract][Full Text] [Related]
16. Influence of dietary portein on the disposition and metabolism of phenylbutazone in rats.
Varma DR
Can J Physiol Pharmacol; 1980 Mar; 58(3):231-6. PubMed ID: 7378926
[TBL] [Abstract][Full Text] [Related]
17. Specimen handling in an HPLC determination of phenylbutazone and its major metabolites in plasma, avoiding degradation of the compounds.
Franssen MJ; Tan Y; Freij I; Van Ginneken CA; Gribnau FW
Pharm Weekbl Sci; 1986 Aug; 8(4):229-33. PubMed ID: 3763367
[TBL] [Abstract][Full Text] [Related]
18. Study of the solid-phase extraction of diclofenac sodium, indomethacin and phenylbutazone for their analysis in human urine by liquid chromatography.
Bakkali A; Corta E; Berrueta LA; Gallo B; Vicente F
J Chromatogr B Biomed Sci Appl; 1999 Jun; 729(1-2):139-45. PubMed ID: 10410936
[TBL] [Abstract][Full Text] [Related]
19. Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens.
Soma LR; Sams R; Duer W; Tobin T; Woodward C; McDonald J
Am J Vet Res; 1985 Apr; 46(4):932-8. PubMed ID: 4014842
[TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatographic determination of proglumide in plasma.
Marunaka T; Minami Y; Umeno Y; Matsushima E
J Pharm Sci; 1982 Aug; 71(8):949-50. PubMed ID: 7120105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
